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INTRODUCTION:  There  is no  medical  treatment  for  alveolar  echinococceal  disease  (AED)  of  liver  till  now.
Curative  surgical  resection  is  optimal  treatment  but  in most  advanced  cases  curative  resection  can’t  be
done.  Liver  transplantation  is accepted  treatment  option  for advanced  AED.  AED  in  some  case  invade
surrounding  tissue  especially  inferior  vena  cava  (IVC). Advanced  AED with invasion  to  IVC can  be treated
with  deceased  liver  transplantation.  Although  living  donor  liver  transplantation  is  very  difﬁcult  to  per-
form  in patients  with  advanced  AED  with  resected  IVC, it come  into  consideration,  since  there  is  very few
cadaveric  liver.
PRESENTATION  OF  CASE:  Here  we  present  a case  with  advanced  stage  of  AED  of liver which  cause  portal
hypertension  and  cholestasis.  AED  invaded  surrounding  tissue,  right  diaphragm,  both  lobes  of liver and
retrohepatic  part  of IVC. Invasion  of  IVC  forced  us to make  resection  of IVC  and  reconstruction  with
cryopreserved  venous  graft  to reestablish  blood  ﬂow.  After  that a  living  donor  liver transplantation  was
done.
DISCUSSION:  Curative  surgery  is  the ﬁrst-choice  option  in  all operable  patients  with  AED  of liver.  Advanced
stage  of  AED  like  chronic  jaundice,  liver  abscess,  sepsis,  repeated  attacks  of cholangitis,  portal  hyperten-
sion,  and  Budd-Chiari  syndrome  may  be  an indication  for  liver  transplantation.  In some  advanced  stage
AED  during  transplantation  replacement  of  retrohepatic  part  of  IVC  could  be done  with  artiﬁcial  vascular
graft,  cadaveric  aortic  and  caval  vein  graft.
CONCLUSION: Although  living  donor  liver  transplantation  with  replacement  of  IVC  is  a very  difﬁcult
operation,  it  should  be considered  in the management  of  advanced  AED  of  liver  with  IVC  invasion  because
of  the  rarity  of  deceased  liver.
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. Introduction
Hepatic AED results from infection by the larval forms of
chinococcus multilocularis. The echinococce almetacestode devel-
ps in the liver and is characterized by an alveolar structure,
Open access under CC BY-NC-NDade up by several vesicles surrounded by large granulomas,
hich grows primarily in the liver of an infected person and
evelops as a cancer like lesion with slow growth.1–5 Partial cura-
ive surgical resection in early stage and liver transplantation
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in advanced stage are accepted treatment options for AED. Many
cases of AED are diagnosed at an advanced stage, hence cura-
tive partial liver resection can be performed in only 35% of
patients 4. Liver transplantation should be accepted as a life-
saving treatment option in patients with AED for whom there
is no other medical or surgical treatment option 1. It is com-
monly known that AED is characterized by strong adhesions and
invasions to the adjacent structures. It complicates the operative
technique and increases morbidity and sometimes may  increase
mortality. 6.The only treatment option for advanced stage of AED
with invasion to IVC is liver transplantation with replacement of
IVC.
Here we present a patient, who underwent the living donor
liver transplantation for hepatic AED with portal hypertension and
se.chronic cholestasis. Strong adhesions to surrounding tissue, right
diaphragm and invasion to the IVC forced us to perform resection
liver with retrohepatic IVC and reconstruction of resected part of
IVC with cryopreserved venous graeft.
s Ltd. Open access under CC BY-NC-ND license.
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oFig. 1. CT view of liver. Compressed IVC is seen with arrow.
. Case report
A  49 year old woman with abdominal ascites and edema of
ower extremities due to advanced stage AED was transferred to
ur center. Levels of aspartate aminotransferase: 41 U/L, alanine
minotransferase: 38 U/L, alkaline phosphatase: 688 U/L, gamma-
lutamyl transpeptidase: 246 U/L, Total bilirubine: 0,88 mg/dl,
irect bilirubine: 0,56 mg/dl, albumin: 2,3 g/dl, BUN: 32 mg/dl and
reatinine: 1,59 mg/dl. International Normalized Ratio:1.9 and the
odel for end stage liver disease score was 11.2. At CT scan it was
ound a cystic lesion 17.3 × 12 × 15 cm in size without any con-
rast collecting during all phases, heterogenic and lobulated with
alciﬁcation on one wall which ﬁlls liver segments V-VIII, and par-
ially extending to segment II and III, (Fig. 1). Indirect echinococcal
emagglutination Bhemagglutination test was positive. Because of
ntrahepatic dissemination of the lesions and IVC compression was
hosen as the method of deﬁnitive treatment. Mercedes incision
ig. 2. a. Removed liver with resected part of retrohepatic part of IVC. b. Resection of IVC a
f  IVC is seen. d. Final view is seen after reconstruction. External drainage tube is seen wiPEN  ACCESS
urgery Case Reports 5 (2014) 169–171
was  chosen for abdominal exploration. Large liver with alveolar
disease and strong widespread adhesions with surrounding tissues,
anterior abdominal wall, right hemidiaphragm and invasion to the
retrohepatic part of IVC made recipient hepatectomy more difﬁ-
cult than other cirrhotic livers. Especially invasion to the IVC forces
us to perform IVC resection with liver(Fig. 2a), and replacement
of resected part of IVC with cryopreserved caval greft (Fig. 2b,2c).
We did not use veno-venous bypass during IVC reconstruction. A
right lobe living related liver transplantation was  done. The donor
was her nephew. Graft/recipient weight ratios was  more than 1%
(680 gr/ 66 kg). Venous and arterial reconstructions were carried
out with a standard method that was mentioned before.6 Thus,
we used cryopreserved vein grafts surrounding the hepatic veins
for extension with 6.0 polypropylene sutures and to make all-
in-one oriﬁce. This provided us an easier and large anastomosis
with replaced IVC. Portal vein patch or extension is not required
for end-to-end porto-portal anastomosis. Portal vein anastomosis
was made with 6.0 polyprolene sutures. Arterial anastomosis was
performed with x6.5 surgical loupes by separated 8.0 polyprolene
sutures. Duct-to-duct biliary anastomosis was  performed, an exter-
nal drainage tube was  placed from cystic ductus of recipient in to
anastomosis.(Fig. 2d). After 10 months follow up period, routine
check-ups of the recipient and the donor were performed. Both of
them didn’t have any problem.
3. Discussion
Surgery is the ﬁrst-choice option in all operable patients with
AED of liver. Radical resection of the entire hepatic parasitic lesions
is the only curative procedure, even though it is often difﬁcult to
achieve because of echinococcal dissemination into host tissues.
Palliative liver surgery is not an ideal option, because it does not
eliminate the disease and makes the secondary treatments more
and more challenging.7 Moreover, its own morbidity and mor-
nd replacement with cryopreserved greft. c. Total replacement of retrohepatic part
th black arrow.
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ality is not lower than expected.5,8 Buttenschoen et al. (2009)
eported that palliative surgery was done in 58% of cases and
urative resection only in 42%. In the palliative surgery group, mor-
idity was 19% and 28% died from AED 164-338 months after the
rst diagnosis (late lethality). The reasons for performing pallia-
ive surgery was sometimes the widespread location of the lesions
n the liver but sometimes the reason may  be the invasions of the
ajor vascularities such as IVC.8 Clinical ﬁndings and complications
f multiple AED like chronic jaundice, liver abscess, sepsis, repeated
ttacks of cholangitis, portal hypertension, and Budd-Chiari syn-
rome may  be an indication for liver transplantation.9,10 In our case
ED invaded all parts of the liver and IVC. Large mass of AED com-
ressing the portal vein and IVC caused portal hypertension and
dema of low extremities, respectively. It was decided to be treated
ith liver transplantation. In 1994 Moreno et al reported ﬁve cases
f OLT for AED. Two of them had secondary sclerosing cholangitis,
wo patient had biliary sclerosis and one patient had post necrotic
iver cirrhosis.3 Xia et al. (2005) also reported ﬁve cases orthotropic
iver transplantatıon for AED.11 Resection and reconstruction of
VC during for AED was reported by Moray et al. They reported
wo cases of liver transplantation for AED and one of them had
peration with resection and replacement of IVC with polytetraﬂu-
roethylene graft1. In our other experience, we  also performed
eplacement of the IVC for living donor liver transplantation in
udd–Chiari syndrome associated with previous hydatid cyst (cys-
ic echinococcosis) surgery. Retrohepatic part of IVC was  replaced
ith a cadaveric aortic graft.6 Matsuda H et al. (2010) presented
wo cases of hepatocellular carcinoma beyond the Milan criteria
nd they were underwent living-donor liver transplantation com-
ined with aggressive hepatic IVC resection and replacement of the
epatic IVC by an artiﬁcial vascular graft. This procedure could be
easible and could prevent post-transplant recurrence in hepatocel-
ular carcinoma beyond the Milan criteria.12 Recently the resection
nd reconstruction of IVC during living donor liver transplanta-
ion was reported by Ueda J et al (2013). They report on a rare
ase of surgical resection of an IVC leiomyosarcoma mimicking a
epatic tumor.13 Most patient series including liver transplanta-
ion for AED are related with deceased donors. Koch et al. studied
5 patients at 16 transplant centers in Europe. According to their
eport, overall 5-year survival and disease-free rates were 71% and
8%, respectively.10 The authors showed that the most important
actor for recurrence and for choosing a treatment option was dis-
ase stage. In our case, the liver, the surrounding tissues and the IVC
emoved completely and IVC was replaced with a cryopreserved
adaveric caval vein graft.
.  Conclusion
Although, living donor liver transplantatıon with IVC replace-
ent for AED with invasion to the IVC is very difﬁcult operation, it
s life - saving option for the patients with advanced stage AED.onﬂict  of interest Statement
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